These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Long-term clinical outcomes of Amplatzer cardiac plug versus Amulet occluders for left atrial appendage closure. Kleinecke C; Cheikh-Ibrahim M; Schnupp S; Fankhauser M; Nietlispach F; Park JW; Brachmann J; Windecker S; Meier B; Gloekler S Catheter Cardiovasc Interv; 2020 Sep; 96(3):E324-E331. PubMed ID: 31631493 [TBL] [Abstract][Full Text] [Related]
7. Percutaneous left atrial appendage occlusion: A review of current devices, clinical evidence, patient selection, and post procedural antithrombotic management. Jackson LR; Jackson KP; Thomas KL Prog Cardiovasc Dis; 2021; 66():92-100. PubMed ID: 34332665 [TBL] [Abstract][Full Text] [Related]
8. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure. Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117 [TBL] [Abstract][Full Text] [Related]
9. Percutaneous Left Atrial Appendage Closure With the Watchman Device: Long-Term Results Up to 5 Years. Wiebe J; Franke J; Lehn K; Hofmann I; Vaskelyte L; Bertog S; Sievert H JACC Cardiovasc Interv; 2015 Dec; 8(15):1915-1921. PubMed ID: 26738659 [TBL] [Abstract][Full Text] [Related]
10. Late clinical outcomes of lambre versus amplatzer occluders for left atrial appendage closure. Schnupp S; Liu XX; Buffle E; Gloekler S; Mohrez Y; Cheikh-Ibrahim M; Allakkis W; Brachmann J; Park JW; Kleinecke C J Cardiovasc Electrophysiol; 2020 Apr; 31(4):934-942. PubMed ID: 32072692 [TBL] [Abstract][Full Text] [Related]
11. Systematic review on left atrial appendage closure with the LAmbre device in patients with non-valvular atrial fibrillation. Ali M; Rigopoulos AG; Mammadov M; Torky A; Auer A; Matiakis M; Abate E; Bakogiannis C; Tzikas S; Bigalke B; Sedding D; Noutsias M BMC Cardiovasc Disord; 2020 Feb; 20(1):78. PubMed ID: 32050904 [TBL] [Abstract][Full Text] [Related]
12. Thromboembolic events and need for anticoagulation therapy following left atrial appendage occlusion in patients with electrical isolation of the appendage. Gadiyaram VK; Mohanty S; Gianni C; Trivedi C; Al-Ahmad A; Burkhardt DJ; Gallinghouse JG; Hranitzky PM; Horton RP; Sanchez JE; Della Rocca DG; Di Biase L; Price MJ; Couts L; Gibson D; Natale A J Cardiovasc Electrophysiol; 2019 Apr; 30(4):511-516. PubMed ID: 30623500 [TBL] [Abstract][Full Text] [Related]
13. Transcatheter left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: results from the Belgian registry. Kefer J; Aminian A; Vermeersch P; de Potter T; Stammen F; Benit E; Budts W; Missault L; Drieghe B; Buysschaert I; Cornelis K; Herzet JM; Guedes A; Debbas N; Rivero M; Lempereur M; Lochy S; Casado-Arroyo R; Laruelle C; Debruyne P; Ledent T EuroIntervention; 2018 Jan; 13(13):1603-1611. PubMed ID: 28966159 [TBL] [Abstract][Full Text] [Related]
14. Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation. Gloekler S; Shakir S; Doblies J; Khattab AA; Praz F; Guerios Ê; Koermendy D; Stortecky S; Pilgrim T; Buellesfeld L; Wenaweser P; Windecker S; Moschovitis A; Jaguszewski M; Landmesser U; Nietlispach F; Meier B Clin Res Cardiol; 2015 Aug; 104(8):656-65. PubMed ID: 25736061 [TBL] [Abstract][Full Text] [Related]
15. Safety profiles of percutaneous left atrial appendage closure devices: An analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) database from 2009 to 2016. Jazayeri MA; Vuddanda V; Turagam MK; Parikh V; Lavu M; Atkins D; Earnest M; Di Biase L; Natale A; Wilber D; Reddy YM; Lakkireddy DR J Cardiovasc Electrophysiol; 2018 Jan; 29(1):5-13. PubMed ID: 28988455 [TBL] [Abstract][Full Text] [Related]
16. Early Canadian Multicenter Experience With WATCHMAN for Percutaneous Left Atrial Appendage Closure. Saw J; Fahmy P; Azzalini L; Marquis JF; Hibbert B; Morillo C; Carrizo A; Ibrahim R J Cardiovasc Electrophysiol; 2017 Apr; 28(4):396-401. PubMed ID: 28128883 [TBL] [Abstract][Full Text] [Related]
17. Outcomes With the WATCHMAN FLX in Everyday Clinical Practice From the NCDR Left Atrial Appendage Occlusion Registry. Kapadia SR; Yeh RW; Price MJ; Piccini JP; Nair DG; Bansal A; Hsu JC; Freeman JV; Christen T; Allocco DJ; Gibson DN Circ Cardiovasc Interv; 2024 Sep; 17(9):e013750. PubMed ID: 39056187 [TBL] [Abstract][Full Text] [Related]
19. Percutaneous left atrial appendage occlusion in mitral valve disease: A Nationwide Readmission Database analysis. Feroze R; Ullah W; Kang P; Lobo T; Alhabdan N; Alghammass M; Yoon SH; Dallan LAP; Filby SJ Cardiovasc Revasc Med; 2024 Jun; 63():23-30. PubMed ID: 38267285 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Left Atrial Appendage Closure With WATCHMAN in Japanese Nonvalvular Atrial Fibrillation Patients - Final 2-Year Follow-up Outcome Data From the SALUTE Trial. Aonuma K; Yamasaki H; Nakamura M; Matsumoto T; Takayama M; Ando K; Hirao K; Goya M; Morino Y; Hayashida K; Kusano K; Gomi Y; Main ML; Uchida T; Saito S Circ J; 2020 Jul; 84(8):1237-1243. PubMed ID: 32595176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]